Can DW-MRI, with its ADC values, be a reliable predictor of biopsy outcome in patients with suspected prostate cancer?

[1] Min BD(2012)Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer Korean J Urol 53 830-835

[2] Kim WT(2014)Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens Prostate Int 2 188-195

[3] Cho BS(2011)Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis AJR Am J Roentgenol 197 1382-1390

[4] Kitamura K(2015)Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review Eur Urol 67 627-636

[5] Muto S(2013)Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis J Comput Assist Tomogr 37 980-988

[6] Yokota I(2015)MR imaging-guided prostate biopsy: technical features and preliminary results Radiol Med 120 571-578

[7] Oto A(2015)The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer Eur Radiol 25 994-1004

[8] Yang C(2014)MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy Eur Radiol 24 2582-2589

[9] Kayhan A(2005)Diffusion-weighted imaging of prostate cancer J Comput Assist Tomogr 29 149-153

[10] Schoots IG(2011)Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 477-494

[1] Min BD(2012)Usefulness of a combined approach of t1-weighted, t2-weighted, dynamic contrast-enhanced, and diffusion-weighted imaging in prostate cancer Korean J Urol 53 830-835

[2] Kim WT(2014)Feasibility of multiparametric prostate magnetic resonance imaging in the detection of cancer distribution: histopathological correlation with prostatectomy specimens Prostate Int 2 188-195

[3] Cho BS(2011)Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis AJR Am J Roentgenol 197 1382-1390

[4] Kitamura K(2015)Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review Eur Urol 67 627-636

[5] Muto S(2013)Prostate cancer: diffusion-weighted imaging versus dynamic-contrast enhanced imaging for tumor localization-a meta-analysis J Comput Assist Tomogr 37 980-988

[6] Yokota I(2015)MR imaging-guided prostate biopsy: technical features and preliminary results Radiol Med 120 571-578

[7] Oto A(2015)The histogram analysis of diffusion-weighted intravoxel incoherent motion (IVIM) imaging for differentiating the gleason grade of prostate cancer Eur Radiol 25 994-1004

[8] Yang C(2014)MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsy Eur Radiol 24 2582-2589

[9] Kayhan A(2005)Diffusion-weighted imaging of prostate cancer J Comput Assist Tomogr 29 149-153

[10] Schoots IG(2011)Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting Eur Urol 59 477-494